Background: The purpose of this study was to assess the overall short-term outcome of stent-graft repair for thoracic aortic disease in France between June 1999 and May 2001. Methods: This retrospective study was desi...Background: The purpose of this study was to assess the overall short-term outcome of stent-graft repair for thoracic aortic disease in France between June 1999 and May 2001. Methods: This retrospective study was designed by the French National Health Insurance Fund for Salaried Workers. To ensure objectivity, data were retrieved at each center and checked by a team of medical advisors. Results: Between June 1999 and May 2001, a total of 166 stent-graft repairs for thoracic aortic disease were performed in 166 patients, mainly by surgeons in the operating room(88% ). Patients were classified according to the American Society of Anesthesiologists as status I or II in 24% of cases, status III in 56% , and status IV or V in 20% . The diameter of the thoracic aneurysm was less than 50 mm in 17% of cases. Seventeen patients(10% ) died during the first 3 months, including 8 within the first 30 days after the procedure. A total of 49 complications were noted in 34 patients(20.5% ). Endoleaks occurred in 27 patients(16.3% ), including 8 that necessitated further treatment. Other stent-related complications included rupture(n=3), aortoesophageal or tracheal fistula(n=3), paraplegia(n=6), stent migration(n=2), visceral embolism(n=5), and cerebral embolism(n=2). There were 14 delivery-related complications(8% ) at the catheterization site. Non-stent- related complications occurred in 14(8% ). Conclusions: This nationwide study demonstrates that stent-graft repair for thoracic aortic disease can be performed with acceptable postoperative morbidity. However, it is not a risk-free procedure and should continue to be used in an investigative setting.展开更多
文摘Background: The purpose of this study was to assess the overall short-term outcome of stent-graft repair for thoracic aortic disease in France between June 1999 and May 2001. Methods: This retrospective study was designed by the French National Health Insurance Fund for Salaried Workers. To ensure objectivity, data were retrieved at each center and checked by a team of medical advisors. Results: Between June 1999 and May 2001, a total of 166 stent-graft repairs for thoracic aortic disease were performed in 166 patients, mainly by surgeons in the operating room(88% ). Patients were classified according to the American Society of Anesthesiologists as status I or II in 24% of cases, status III in 56% , and status IV or V in 20% . The diameter of the thoracic aneurysm was less than 50 mm in 17% of cases. Seventeen patients(10% ) died during the first 3 months, including 8 within the first 30 days after the procedure. A total of 49 complications were noted in 34 patients(20.5% ). Endoleaks occurred in 27 patients(16.3% ), including 8 that necessitated further treatment. Other stent-related complications included rupture(n=3), aortoesophageal or tracheal fistula(n=3), paraplegia(n=6), stent migration(n=2), visceral embolism(n=5), and cerebral embolism(n=2). There were 14 delivery-related complications(8% ) at the catheterization site. Non-stent- related complications occurred in 14(8% ). Conclusions: This nationwide study demonstrates that stent-graft repair for thoracic aortic disease can be performed with acceptable postoperative morbidity. However, it is not a risk-free procedure and should continue to be used in an investigative setting.
